Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease-Reference-Cited by-同舟云学术

Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease

Published:2005-07-05 Issue:1 Volume:143 Page:20
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Ethgen Morgane¹,Boutron Isabelle¹,Baron Gabriel¹,Giraudeau Bruno¹,Sibilia Jean¹,Ravaud Philippe¹

Affiliation:

1. From Centre Hospitalier Universitaire de Hautepierre, Strasbourg, France; Hôpital Bretonneau, Tours, France; and Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe Hospitalier Bichat-Claude Bernard, and Université Paris VII, Paris, France.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update;Annals of the Rheumatic Diseases;2024-01-11

2. Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis;Rheumatology International;2023-11-30

3. Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review;Frontiers in Immunology;2022-07-07

4. No difference in clinical outcome at 2-year follow-up in patients with type III and V acromioclavicular joint dislocation treated with hook plate or physiotherapy: a randomized controlled trial;Journal of Shoulder and Elbow Surgery;2022-06

5. Reporting of Harm in Randomized Controlled Trials of Therapeutic Exercise for Knee Osteoarthritis: A Systematic Review;Physical Therapy;2021-06-26